grant

Human ISG15 and USP18 Deficiencies Underlying Type I Interferonopathies

Organization COLUMBIA UNIVERSITY HEALTH SCIENCESLocation NEW YORK, UNITED STATESPosted 16 Apr 2024Deadline 31 May 2027
NIHUS FederalResearch GrantFY20250-11 years old2019 novel corona virus2019 novel coronavirus2019-nCoVAIDS VirusAPF-1ATP-Dependent Proteolysis Factor 1Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAffectAicardi Goutieres syndromeAlpha-Beta-Omega Interferon Receptor-1Anti-InflammatoriesAnti-Inflammatory AgentsAnti-inflammatoryAnti-viral AgentsAnti-viral ResponseAnti-viral resistanceAntiviral Protein Alpha TypeAstrocytesAstrocytusAstrogliaAutoimmuneAutoimmune DiseasesBlood CellsBody TissuesCOVID-19 virusCOVID19 virusCREE ENCEPHALITISCalcifiedCell BodyCell Communication and SignalingCell LineCell NucleusCell SignalingCellLineCellsChildChild YouthChildren (0-21)ClinicalCoV-2CoV2CollectionComplexDNA VirusesDevelopmentDiseaseDisorderDown-RegulationDysfunctionEncephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluidEncephalopathy, familial infantile, with calcification of basal ganglia and chronic cerebrospinal fluid lymphocytosisExposure toFunctional disorderGeneralized GrowthGenerationsGenesGeneticGoalsGrowthHIVHMG-20HSVHealthHemagglutinating Virus of JapanHerpes Simplex VirusHerpes labialis VirusHigh Mobility Protein 20Hortega cellHuIFN-Alpha-RecHumanHuman Immunodeficiency VirusesIFNIFNBRIFRCISG15ISG15 geneImmune responseImmunochemical ImmunologicImmunologicImmunologicalImmunologicallyImmunologicsIn VitroIndividualInfectionInflammationInflammatoryInfluenza AInfluenza A virusInfluenza BInfluenza B VirusInfluenza Viruses Type AInfluenza Viruses Type BInfluenzavirus AInterferon Alpha-Beta Receptor Alpha ChainInterferon Type IInterferon-Induced Protein IFI-15KInterferonsIntracellular Communication and SignalingLAV-HTLV-IIILaboratoriesLymphadenopathy-Associated VirusLymphatic TissueLymphoid TissueMeasuresMediatingMicrogliaModern ManMolecularNerve CellsNerve UnitNervous System DiseasesNervous System DisorderNeural CellNeural Stem CellNeurocyteNeurologicNeurologic DisordersNeurologic ManifestationsNeurologic Signs and SymptomsNeurologic SymptomsNeurologicalNeurological DisordersNeurological ManifestationsNeurological Signs and SymptomsNeuronsNon-Polyadenylated RNANucleusOrthomyxovirus Type AOrthomyxoviruses Type BOutcomePathogenesisPathogenicityPathway interactionsPatientsPeripheral Blood CellPhagocytosisPhosphorylationPhysiopathologyPredispositionProductionPropertyProtein PhosphorylationProteinsProteomeRNARNA Gene ProductsRNA SeqRNA VirusesRNA sequencingRNAseqRegulationResistanceRibonucleic AcidRoleSARS corona virus 2SARS-CO-V2SARS-COVID-2SARS-CoV-2SARS-CoV2SARS-associated corona virus 2SARS-associated coronavirus 2SARS-coronavirus-2SARS-related corona virus 2SARS-related coronavirus 2SARSCoV2SPENCDSendai virusSevere Acute Respiratory Coronavirus 2Severe Acute Respiratory Distress Syndrome CoV 2Severe Acute Respiratory Distress Syndrome Corona Virus 2Severe Acute Respiratory Distress Syndrome Coronavirus 2Severe Acute Respiratory Syndrome CoV 2Severe Acute Respiratory Syndrome-associated coronavirus 2Severe Acute Respiratory Syndrome-related coronavirus 2Severe acute respiratory syndrome associated corona virus 2Severe acute respiratory syndrome coronavirus 2Severe acute respiratory syndrome related corona virus 2Signal TransductionSignal Transduction SystemsSignalingSimplexvirusSpecificitySpondyloenchondrodysplasiaStrains Cell LinesSusceptibilitySynaptosomesTestingTherapeutic AgentsTissue GrowthTissue ModelTissuesTranscription InitiationType A InfluenzaType I InterferonopathyUSP18 deficiencyUbiquitinUpregulationVSVVesicular Stomatitis VirusVesicular stomatitis Indiana virusViralViral DiseasesVirusVirus DiseasesVirus-HIVWuhan coronavirusZIKVZika Virusanti-viral compoundanti-viral drugsanti-viral immunityanti-viral medicationanti-viral resistantanti-viral therapeuticanti-viralsantiviral immunityastrocytic gliaautoimmune conditionautoimmune disorderautoimmunity diseaseautoinflammatoryautoinflammatory diseasesautoinflammatory disordersautosomebiological signal transductioncalcificationcell typecoronavirus disease 2019 viruscoronavirus disease-19 viruscultured cell linecytokinedesigndesigningdevelopmentalgene productgitter cellhCoV19hiPSChost responsehuman iPShuman iPSChuman induced pluripotent cellhuman induced pluripotent stem cellshuman inducible pluripotent stem cellshuman inducible stem cellsifnar1 gene productimmune system responseimmunoresponseimprovedin vivoinduced human pluripotent stem cellskidsmesogliamicrocephaly-chorioretinopathy syndromemicroglial cellmicrogliocytemutantnCoV2nerve stem cellneural manifestationneural precursorneural precursor cellneural progenitorneural progenitor cellsneural stem and progenitor cellsneurogenic progenitorsneurogenic stem cellneurological diseaseneuron progenitorsneuronalneuronal progenitorneuronal progenitor cellsneuronal stem cellsneuroprogenitorontogenypathophysiologypathwayperivascular glial cellpreservationprogenitor and neural stem cellspseudotoxoplasmosis syndromeresistantresponsesocial rolespondyloenchondromatosissynaptoneurosometranscriptome sequencingtranscriptomic sequencingtype I IFN receptortype I interferon receptorviral infectionviral resistancevirus infectionvirus resistancevirus-induced diseaseyoungsterzikav
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary
Type I interferons (IFN-Is) have well-documented potent antiviral and inflammatory properties. However,

we and others have shown that the inflammatory effects of these cytokines can have detrimental effects on

human health. Disorders caused by the prolonged effects of IFN-Is are collectively known as type I

interferonopathies. Mendelian type I interferonopathies, such as Aicardi–Goutières syndrome (AGS) and

spondyloenchondromatosis (SPENCD) are prime examples of severe neurologic, autoinflammatory and

autoimmune diseases caused by the perpetual induction of IFN-Is.

We have recently described more than 20 children presenting Mendelian type I interferonopathy.

Genetically, we have shown these conditions to be due to complete or partial deficiencies of ISG15 or USP18.

These deficiencies affect downregulation of the IFN-I response. Individuals with deficiencies of ISG15 or USP18

have high levels of IFN-I-stimulated gene products in their blood cells, high levels of resistance to viral infections,

but also neurologic, autoinflammatory and autoimmune manifestations, akin to those of AGS and SPENCD. This

proposal is built around the hypothesis that the pathogenesis of these deficiencies is driven by IFN-I responses

in specific tissues, and that these responses could be harnessed in the development of new treatments. We plan

to test this hypothesis by studying these deficiencies in vitro, ex vivo, and in vivo at the molecular, immunological,

and tissue-specific levels, to determine their functional significance in IFN-I pathway regulation and resistance

to viral infections in humans.

Improvements in our understanding of the molecular regulation of IFN-I should shed light on the

pathophysiology of these deficiencies, paving the way for the development of new treatments for managing

persistent inflammatory disorders and enhancing antiviral responses.

Grant Number: 5R01AI127372-09
NIH Institute/Center: NIH

Principal Investigator: Dusan Bogunovic

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →